Cost of Heart Failure in Patients Receiving -Blockers and Angiotensin-Converting Enzyme Inhibitors

By Weintraub W.S.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite

The Application of Angiotensin Converting Enzyme Inhibitors in Heart Surgery

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 105-108

Bentham Science Publishers

Access to resources Recommend Favorite

Acute Administration of Angiotensin Converting Enzyme Inhibitors in Thrombolysed Myocardial Infarction Patients Is Associated with a Decreased Incidence of Heart Failure, but an Increased Re-Infarction Risk

By Voors Adriaan   Kam Pieter   Berg Maarten   Borghi Claudio   Hochman Judith   Veldhuisen Dirk   Gilst Wiek  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 119-124

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

By  

Fundamental & Clinical Pharmacology, Vol. 32, Iss. 1, 2018-02 ,pp. : 14-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin Antagonism in Patients with Heart Failure: ACE Inhibitors, Angiotensin Receptor Antagonists or Both?

By Nicholas L.M. Cruden   David E. Newby  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 345-353

Adis International

Access to resources Recommend Favorite